Haemonetics

Haemonetics is a Boston-based medical technology company founded in 1971 that develops and manufactures blood management solutions including automated blood processing devices, blood bank information management systems, and patient blood management monitoring technologies used in hospitals, blood collection centers, and research settings. The company's MCS+ and Aurora apheresis systems are used by blood collection agencies to perform automated platelet and plasma collection from volunteer donors, improving collection efficiency and product quality compared to whole blood donations. For hemostasis research, Haemonetics's TEG (Thromboelastography) system is a viscoelastic hemostatic assay widely used in operating rooms and research labs to characterize whole blood coagulation status in real time, measuring clot initiation, propagation, strength, and fibrinolysis in a single test from a small blood sample. TEG has become an important research tool in trauma, cardiac surgery, liver transplantation, and obstetric hemorrhage studies, where its ability to rapidly identify coagulopathy phenotypes guides transfusion therapy decisions and has enabled research into goal-directed transfusion protocols. Haemonetics's BloodTrack blood bank management system and SafeTrace Tx transfusion management software handle electronic crossmatch, inventory management, and regulatory reporting for hospital blood banks and support transfusion medicine clinical research. Their Cell Saver blood conservation systems process shed blood during major surgery for autologous re-infusion, and the research data from their use has shaped evidence-based guidelines for blood conservation in cardiac and orthopedic surgery.